K
Kamada Ltd. (KMDA)
NMS – Real vaqt narxi. Valyuta: USD
8.43
-0.02 (-0.24%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
8.43
-0.02 (-0.24%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Kamada Ltd. plazmadan olingan oqsil terapiyasini ishlab chiqaradi va sotadi. Mahsulotlari orasida quturishning oldini olish uchun KAMRAB/KEDRAB; buyrak, o'pka, jigar, oshqozon osti bezi, yurak va yurak/o'pka transplantatsiyalarida sitomegalovirus kasalligining oldini olish uchun CYTOGAM; suyak iligi kasalligining oldini olish uchun VARIZIG; immunitetli trombotsitopenik purpura va rezus izoimmunizatsiyasini bostirish uchun WINRHO SDF; jigar transplantatsiyasidan keyin B gepatitining takrorlanishini va postekspozitsion profilaktikasini oldini olish uchun HEPAGAM B; tomir ichiga AATD uchun GLASSIA; yangi tug'ilgan chaqaloqlarda gemolitik kasallikning oldini olish uchun KAMRHO (D) IM; va ilon chaqishini davolash uchun Echis coloratus va Vipera palaestinae zahariga qarshi zardob kiradi. Kompaniya Isroilda BRAMITOB, astmani davolash uchun FOSTER, surunkali o'pka kasalligini davolash uchun TRIMBOW, bronxial nafas yo'llarining giperaktivligini tashxislash uchun PROVOCHOLINE, OPEP qurilmasi AEROBIKA, allergik rinit va ürtiker uchun RUPAFIN va RUPAFIN ORAL SOLUTION, revmatoid artrit, tizimli qizil yug'rich va engil-o'rtacha yoshdagi dermatomiyozit uchun SINTREDIUS, turli immunitet tanqisligi bilan bog'liq kasalliklar uchun IVIG, chechak va shingles uchun VARITECT, B gepatitini oldini olish uchun ZUTECTRA va HEPATECT CP, CMV virusi uchun MEGALOTECT CP, angionevrotik shish hujumlari uchun RUCONEST, tromboembolik kasalliklar va chuqur venoz tromboz va tromboembolik hodisalarning oldini olish uchun heparin natriy in'ektsiyasi, qon plazmasi uchun ALBUMIN va ALBUMIN, A turdagi gemofiliya uchun VIII omil va B turdagi gemofiliya uchun IX omil kabi biyo-farmatsevtika mahsulotlarini ham tarqatadi. Bundan tashqari, irsiy X omil etishmovchiligini davolash uchun COAGADEX; yapon ensefaliti uchun IXIARO; tif salmonellyozi uchun VIVOTIF; nefropatik sistinoz uchun PROCYSBI; alfa-mannosidoz uchun LAMZEDE; gipoplazminogenemiya uchun RYPLAZIM; prostata saratoni uchun ELIGARD; va turli saraton turlari uchun BEVACIZUMAB KAMADA ni tarqatadi. Kompaniya 1990 yilda tashkil etilgan va Isroilning Rehovot shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Amir London | Chief Executive Officer |
| Mr. Boris Gorelik | Vice President of Business Development & Strategic Programs |
| Mr. Chaime Orlev | Chief Financial Officer |
| Mr. David Tsur | Co-Founder & Independent Deputy Chairman of the Board |
| Mr. Eran Nir | Chief Operating Officer |
| Mr. Jon R. Knight | Vice President of US Commercial Operations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | 6-K | ea0289381-6k_kamada.htm |
| 2026-03-31 | 6-K | ea0283955-6k_kamada.htm |
| 2026-03-26 | 6-K | ea0283431-6k_kamada.htm |
| 2026-03-17 | 6-K | ea0281980-6k_kamada.htm |
| 2026-03-11 | 6-K | ea0280560-6k_kamada.htm |
| 2026-03-04 | 6-K | ea0279964-6k_kamada.htm |
| 2026-01-07 | 6-K | ea0272041-6k_kamada.htm |
| 2025-12-18 | 6-K | ea0270198-6k_kamada.htm |
| 2025-12-10 | 6-K | ea0269087-6k_kamada.htm |
| 2025-12-08 | 6-K | ea0268786-6k_kamada.htm |
| Mr. Nir Livneh B.A., L.L.B. | VP, General Counsel & Corporate Secretary |
| Ms. Hanni Neheman | Vice President of Marketing & Sales |
| Ms. Liron Reshef | Vice President of Human Resources |
| Ms. Shavit Beladev | Vice President of Kamada Plasma |